iShares Biotechnology ETF $IBB Shares Sold by Traynor Capital Management Inc.

Traynor Capital Management Inc. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 29.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,278 shares of the financial services provider’s stock after selling 4,597 shares during the period. Traynor Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,628,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the company. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,000. Berkshire Money Management Inc. acquired a new stake in iShares Biotechnology ETF in the 2nd quarter worth about $28,000. Financial Gravity Companies Inc. purchased a new stake in iShares Biotechnology ETF in the 2nd quarter valued at about $29,000. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $36,000. Finally, Harbor Asset Planning Inc. purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth about $31,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $174.03 on Thursday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64. The company’s 50 day simple moving average is $171.15 and its 200 day simple moving average is $154.00.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were given a $0.1831 dividend. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $0.73 annualized dividend and a dividend yield of 0.4%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.